523 results match your criteria: "The Daffodil Centre[Affiliation]"
Indian J Med Res
May 2024
The Daffodil Centre, University of Sydney, a joint venture with Cancer Council NSW, Sydney, Australia.
J Cancer Surviv
October 2024
School of Psychology, Psycho-Oncology Cooperative Research Group, The University of Sydney, Sydney, NSW, Australia.
J Med Imaging (Bellingham)
September 2024
The University of Sydney, Faculty of Health Sciences, Discipline of Medical Imaging Science, Sydney, New South Wales, Australia.
Purpose: Accurate interpretation of mammograms presents challenges. Tailoring mammography training to reader profiles holds the promise of an effective strategy to reduce these errors. This proof-of-concept study investigated the feasibility of employing convolutional neural networks (CNNs) with transfer learning to categorize regions associated with false-positive (FP) errors within screening mammograms into categories of "low" or "high" likelihood of being a false-positive detection for radiologists sharing similar geographic characteristics.
View Article and Find Full Text PDFPublic Health
December 2024
Division of Prevention, National Cancer Center Institute for Cancer Control, Japan.
Eur Radiol
October 2024
The Daffodil Centre, The University of Sydney, A Joint Venture with Cancer Council NSW, Sydney, NSW, Australia.
Objectives: We aimed to synthesise evidence from prospective studies of digital breast tomosynthesis (DBT) screening to assess its effectiveness compared to digital mammography (DM). Specifically, we examined whether DBT reduces interval cancer rates (ICRs) in population breast cancer screening.
Materials And Methods: We performed a systematic review and meta-analysis of DBT screening studies (identified from January 2013 to March 2024).
Aust Health Rev
December 2024
Caring Futures Institute, College of Nursing and Health Sciences, Flinders University, SA, Australia; and Cancer and Palliative Care Outcomes Centre, Faculty of Health, Queensland University of Technology (QUT), Qld, Australia; and Human Performance Research Centre, INSIGHT Research Institute, University of Technology Sydney (UTS), NSW, Australia; and Exercise Medicine Research Institute, School of Medical and Health Sciences, Edith Cowan University, Perth, WA, Australia; and Institute for Health Research, University of Notre Dame Australia, WA, Australia.
Objective Chronic disease is common in people with cancer. However, the utilisation of Medicare chronic disease management (CDM) items for cancer patients in Australia remains unexplored. This study investigates Medicare CDM item numbers relating to people with cancer, including general practitioner (GP) and allied health CDM item numbers, and any associated sociodemographic factors.
View Article and Find Full Text PDFAust N Z J Public Health
October 2024
School of Public Health, University of Technology Sydney, Australia.
Objective: To assess pharmacists' knowledge regarding emergency contraceptive pills (ECPs), their attitudes towards women obtaining ECPs, and ECP counselling and dispensing practices.
Methods: An online cross-sectional survey using Qualtrics was distributed via pharmacy emails and networks to recruit registered pharmacists working in community-based pharmacies.
Results: There were 22 valid respondents, predominantly female pharmacists (68%), with an average of 7.
Stud Health Technol Inform
September 2024
UNSW Sydney School of Computer Science and Engineering, Australia.
Advances in cancer treatment have improved patient outcomes and survival in recent decades. Increased complexity, duration, and individualisation of treatment protocols present an important challenge for care teams monitoring adherence to best-practice care. A rigid rules-based system for flagging outliers is not fit for purpose, as there are sound reasons for deviating from baseline protocols, such as the management of treatment side effects to a tolerable degree, however the methods for determining the bounds of appropriateness for variation are not well studied or understood.
View Article and Find Full Text PDFJ Natl Cancer Inst
September 2024
Dermatology Research Centre, The University of Queensland, Frazer Institute, Brisbane, Queensland, Australia.
Genomic testing can inform the diagnosis and personalise management of cancers in children, adolescents, and young adults (CAYA). This scoping review explored the clinical utility and impact of genomic testing in general CAYA cancer cohorts. Relevant records published in English between 2017-2024 were identified by searching PubMed.
View Article and Find Full Text PDFVox Sang
December 2024
Research and Development, Australian Red Cross Lifeblood, Sydney, New South Wales, Australia.
Background And Objectives: Several studies have suggested that blood donors have lower risk of gastrointestinal and breast cancers, whereas some have indicated an increased risk of haematological cancers. We examined these associations by appropriately adjusting the 'healthy donor effect' (HDE).
Materials And Methods: We examined the risk of gastrointestinal/colorectal, breast and haematological cancers in regular high-frequency whole blood (WB) donors using the Sax Institute's 45 and Up Study data linked with blood donation and other health-related data.
Genet Med
December 2024
The University of Sydney, Faculty of Medicine and Health, Sydney School of Public Health, Sydney Health Ethics, Sydney, NSW, Australia. Electronic address:
Psychiatry Res
December 2024
Australian Centre for Precision Health, Unit of Clinical & Health Sciences, University of South Australia, Adelaide, SA 5000, Australia; South Australian Health and Medical Research Institute, Adelaide, SA 5000, Australia.
Maternal adiposity (overweight or obesity) has been associated with adverse perinatal outcomes, although the potential risks of long-term neuropsychiatric and behavioral outcomes in the offspring remain unclear. Using the PRISMA guidelines, we searched PubMed, EMBASE, Scopus, and Web of Science to identify studies on maternal adiposity and offspring neuropsychiatric outcomes. Inverse variance-weighted random-effects meta-analyses were used to pool effect estimates with 95 % confidence intervals (95 % CIs) from adjusted odds ratios (OR) and hazard ratios (HR).
View Article and Find Full Text PDFBreast
December 2024
The Daffodil Centre, University of Sydney, a Joint Venture with Cancer Council NSW, Sydney, Australia; School of Public Health, Faculty of Health and Medicine, University of Sydney, Sydney, NSW, Australia.
Background: Biopsy-proven breast lesions such as atypical ductal hyperplasia (ADH) or atypical lobular hyperplasia (ALH), lobular carcinoma in situ (LCIS) and flat epithelial atypia (FEA) increase subsequent risk of breast cancer (BC), but long-term risk has not been synthesized. A systematic review was conducted to quantify future risk of breast cancer accounting for time since diagnosis of these high-risk lesions.
Methods: A systematic search of literature from 2000 was performed to identify studies reporting BC as an outcome following core-needle or excision biopsy histology diagnosis of ADH, ALH, LCIS, lobular neoplasia (LN) or FEA.
Aust N Z J Public Health
October 2024
Prevention Research Collaboration, School of Public Health, Faculty of Medicine and Health, The University of Sydney, Camperdown, Australia.
Objective: The objective of this study was to estimate the association between vaping and subsequent initiation of smoking among Australian adolescents and explore the impact of design and analytical methods in previous studies.
Methods: We conducted a retrospective cohort analysis of cross-sectional data from 5114 Australian adolescents aged 14-17 recalling information on smoking and vaping initiation from age 12 to 17. The outcome was smoking initiation, analysed with negative-binomial regression to estimate incidence rate ratios (IRRs) for vape status (ever-vaped vs never-vaped) as a time-varying exposure.
J Natl Cancer Inst
January 2025
Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales (NSW), Australia.
The prognosis of a patient with a primary cutaneous melanoma is known to be related to the Breslow thickness of their tumor. This study sought to determine long-term (30-year) survival rates for the 4 American Joint Committee on Cancer 8th edition T categories by analyzing Australian registry data for 210 042 melanoma patients diagnosed from 1982 to 2014. The 30-year incidence rates of death due to melanoma and nonmelanoma (with 95% confidence intervals [CIs]) were 7.
View Article and Find Full Text PDFNicotine Tob Res
September 2024
Faculty of Medicine and Health, Sydney School of Public Health, The University of Sydney, New South Wales, Australia.
Introduction: Lung cancer screening (LCS) trials, targeting people with smoking history, have demonstrated reduced mortality. How to optimally embed evidence-based smoking cessation support in LCS, including in Australia, needs to be better understood. We sought experts' perspectives to identify potential barriers and effective implementation strategies.
View Article and Find Full Text PDFInt J Cancer
January 2025
Population Health Program, QIMR Berghofer Medical Research Institute, Brisbane, Australia.
Menopausal hormone therapy (MHT) use before ovarian cancer diagnosis has been associated with improved survival but whether the association varies by type and duration of use is inconclusive; data on MHT use after treatment, particularly the effect on health-related quality of life (HRQOL), are scarce. We investigated survival in women with ovarian cancer according to MHT use before and after diagnosis, and post-treatment MHT use and its association with HRQOL in a prospective nationwide cohort in Australia. We used Cox proportional hazards regression to estimate hazard ratios (HR) and 95% confidence intervals (CI) and propensity scores to reduce confounding by indication.
View Article and Find Full Text PDFJ Med Virol
September 2024
Institute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
While HC2 and GP5+/6+ PCR-EIA were pivotal in test validation of new HPV assays, they represent the first generation of comparator tests based upon technologies that are not in widespread use anymore. In the current guideline, criteria for second-generation comparator tests are presented that include more detailed resolution of HPV genotypes. Second-generation comparator tests should preferentially target only the 12 genotypes classified as carcinogenic (IARC-group I), and show consistent non-inferior sensitivity for CIN2+ and CIN3+ and specificity for ≤CIN1 compared to one of the first-generations comparators, in at least three validation studies using benchmarks of 0.
View Article and Find Full Text PDFPrev Med Rep
September 2024
The Daffodil Centre, The University of Sydney, a joint venture with Cancer Council NSW, Australia.
Objective: The coronavirus pandemic impacted health-seeking behaviour and access to primary care in Australia. We investigated factors associated with intention-to-attend and attendance of cervical screening during the pandemic, mainly in Victoria, Australia.
Methods: We used questionnaire and attendance data (Aug 2020-Nov 2022) from Compass-PLUS, a sub-study of the Compass randomized-controlled trial of Human Papillomavirus-based vs cytology-based screening.
Lancet Reg Health West Pac
September 2024
The Kirby Institute, UNSW Sydney, NSW, Australia.
Background: School-based targeted preventive chemotherapy (PC), the primary strategy for soil-transmitted helminth (STH) control, typically focusing on primary schoolchildren, was expanded to secondary school students in the Philippines in 2016. This program still excludes adults, who may also suffer from considerable morbidity and can be a significant reservoir of infection. Mass drug administration (MDA), where the entire population is treated, would bring additional health benefits but will also increase implementation costs.
View Article and Find Full Text PDFMed J Aust
September 2024
Melanoma Institute Australia, the University of Sydney, Sydney, NSW.
Gastroenterology
January 2025
Decision Modeling Center, Department of Epidemiology and Data Science, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam Public Health, Amsterdam, The Netherlands.
J Infect Dis
August 2024
Centre for Women's Infectious Diseases, The Royal Women's Hospital, Melbourne, Victoria, Australia.
Eur J Surg Oncol
November 2024
Surgical Outcomes Research Centre (SOuRCe), Royal Prince Alfred Hospital, Sydney, New South Wales, Australia; Faculty of Medicine and Health, Central Clinical School, The University of Sydney, New South Wales, Australia; RPA Institute of Academic Surgery, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. Electronic address:
Introduction: Pelvic exenteration provides significant survival benefits for selected patients diagnosed with locally advanced rectal cancer. However, in-hospital postoperative morbidity such as abdominal abscess, sepsis, and anastomotic leak remain highly prevalent, which can have short/long-term impacts on patient quality of life (QoL). The aim of this study was to determine the influence of postoperative morbidity on QoL outcomes in patients following pelvic exenteration.
View Article and Find Full Text PDF